Primary Job Title CEO Primary Organization 
Omniox
Location San Francisco, California, United States Regions San Francisco Bay Area, West Coast, Western US Gender Male
LinkedIn View on LinkedIn
Jonathan Winger is co-inventor of the H-NOX technology, company Co-Founder, and Senior Director of Biochemistry and Manufacturing. He directs the design and biochemical characterization of protein variants with the kinetic and stability properties appropriate for each of the diseases in which H-NOX will be used, as well as oversees in-house protein
production and quality control. He also manages the transfer of upstream and downstream processes for scale-up and GMP manufacturing of material for toxicology studies and clinical trials.
Jonathan has 18 years of experience in diverse biochemical and biophysical methods for production and study of H-NOX and other heme proteins. He has published a number of peer reviewed research papers, co-authored several book chapters, and is an inventor on multiple patents. Prior to Omniox, he was an American Heart Association Postdoctoral Fellow with John Kuriyan at the University of California, Berkeley, where he developed expertise in biophysical techniques including X-ray crystallography, small-angle X-ray scattering, and NMR. He obtained his PhD in Medicinal Chemistry with Michael Marletta at the University of Michigan, where he used spectroscopy and enzymology to investigate the role of soluble guanylate cyclase (sGC), an H-NOX domain-containing protein, in nitric oxide signaling pathways. Insights gained from this work contributed to the conception and founding of Omniox.
